September 2022 Issue Table Of Contents
Source: Life Science Leader

From The Editor
Feature Articles
- Bayer Brings External Innovation Inside, With Guardrails
- Conducting A Drug Development Orchestra To Treat Mental Illness
CEO Corner
Companies To Watch
Industry Research
Podcast Summary
Inside The Industry
- Is AI/ML Bringing Medicines To Patients Faster And Cheaper?
- Life Sciences CIO Survey Illuminates Tech Trends
- Overlooking Building A Compelling Corporate Narrative Is A Big Mistake
- In A Tighter VC Environment, Biopharmas Need To Get Valuation Right
- Nonprofit Pursues Oncology Drugs
- Making An Unapprovable Drug Product Approvable
- The Case For Implementing TransCelerate's Modernization Of Statistical Analysis Framework
Industry Leader
- How To Advance A Disruptive Therapeutic Approach
- The Secret To The Modern CFO’s Success
- Why Biopharma Needs To Catch Up On Lean Practices And Continuous Learning
Leadership Lessons
Ask The Board
- What Can Preclinical Or Early-Stage Biotech Companies Do In The Current Market To Better Access Needed Capital And Resources?
- How Can Biopharma Companies Effectively Maintain Quality And Manage Risk While Rapidly Scaling Up Operations?
- What Can Small Biotech Companies Do To Prepare For Worsening Macroeconomic Conditions?
This website uses cookies to ensure you get the best experience on our website. Learn more